litlas
Log inCreate account

Rema Raman

Active 1997–2025

Also published as
REMA RAMAN
141
Papers
19,385
Citations
74
h-index
123
i10-index

Citations

Citations per year for Rema Raman1958: 1 citations1962: 1 citations1978: 1 citations1981: 1 citations1991: 1 citations1997: 1 citations1998: 2 citations1999: 4 citations2000: 9 citations2001: 13 citations2002: 29 citations2003: 25 citations2004: 35 citations2005: 61 citations2006: 66 citations2007: 71 citations2008: 86 citations2009: 118 citations2010: 105 citations2011: 117 citations2012: 135 citations2013: 119 citations2014: 194 citations2015: 198 citations2016: 248 citations2017: 249 citations2018: 234 citations2019: 643 citations2020: 707 citations2021: 738 citations2022: 637 citations2023: 574 citations2024: 1,132 citations2025: 740 citations2026: 41 citations1959–1961: no citations, so these years are not shown1963–1977: no citations, so these years are not shown1979–1980: no citations, so these years are not shown1982–1990: no citations, so these years are not shown1992–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,103 citing papers, 28.3% of this breakdownUnited Kingdom: 888 citing papers, 8.1% of this breakdownChina: 762 citing papers, 6.9% of this breakdownGermany: 501 citing papers, 4.6% of this breakdownCanada: 468 citing papers, 4.3% of this breakdownSweden: 426 citing papers, 3.9% of this breakdownAustralia: 411 citing papers, 3.8% of this breakdownItaly: 386 citing papers, 3.5% of this breakdownFrance: 377 citing papers, 3.4% of this breakdownNetherlands: 329 citing papers, 3% of this breakdownSpain: 309 citing papers, 2.8% of this breakdownJapan: 243 citing papers, 2.2% of this breakdown
0%28.3%Other 25.2%

Institutions

Fields

  • Medicine70.5%
  • Neuroscience10%
  • Biochemistry, Genetics and Molecular Biology8.1%
  • Nursing2.6%
  • Psychology2.5%
  • Computer Science1.7%
  • Other4.6%

Topics

  • Alzheimer's disease research and treatments13.6%
  • Dementia and Cognitive Impairment Research9.8%
  • Cholinesterase and Neurodegenerative Diseases3.5%
  • Parkinson's Disease Mechanisms and Treatments2.4%
  • Computational Drug Discovery Methods2.3%
  • Neuroinflammation and Neurodegeneration Mechanisms2.2%
  • Other66.2%

Coauthors

All papers

Open in search
  1. Trial of Solanezumab in Preclinical Alzheimer’s Disease

    Authors: Reisa A. Sperling, Michael Donohue, Rema Raman, Michael S. Rafii, Keith Johnson, Colin L. Masters, Christopher H. van Dyck, Takeshi Iwatsubo, Gad A. Marshall, R. Yaari, Michele Mancini, Karen C. Holdridge, Michael Case, John R. Sims, Paul Aisen - New England Journal of Medicine 2023 cited by 379

  2. The Preclinical Alzheimer Cognitive Composite

    Authors: Michael Donohue, Reisa A. Sperling, David P. Salmon, Dorene M. Rentz, Rema Raman, Ronald G. Thomas, Michael Weiner, Paul Aisen - JAMA Neurology 2014 cited by 868

  3. Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

    Authors: Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul Aisen, Eric Siemers, Hong Liu‐Seifert, Richard C. Mohs - New England Journal of Medicine 2014 cited by 1,647

  4. The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease

    Authors: Michael S. Rafii, Reisa A. Sperling, Michael Donohue, Jin Zhou, Claire Roberts, Michael C. Irizarry, Shobha Dhadda, Gopalan Sethuraman, Lynn D. Kramer, Chad J. Swanson, David Li, Stephen Krause, Robert A. Rissman, Sarah Walter, Rema Raman, Keith A. Johnson, Paul Aisen - Alzheimer s & Dementia 2022 cited by 264

  5. World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia

    Authors: Miia Kivipelto, Francesca Mangialasche, Heather M. Snyder, Ricardo Allegri, Sandrine Andrieu, Hidenori Arai, Laura D. Baker, Sylvie Belleville, Henry Brodaty, Sônia Maria Dozzi Brucki, Ismael Luis Calandri, Paulo Caramelli, Christopher Chen, Howard Chertkow, Effie Chew, Seong Hye Choi, Neerja Chowdhary, Lucía Crivelli, Rafael de la Torre, Yifeng Du, Tarun Dua, Mark A. Espeland, Howard Feldman, Maris Hartmanis, Tobias Hartmann, Megan Heffernan, Christiani Jeyakumar Henry, Chang Hyung Hong, Krister Håkansson, Takeshi Iwatsubo, Jee Hyang Jeong, Gustavo Jimenez‐Maggiora, Edward H. Koo, Lenore J. Launer, Jenni Lehtisalo, Francisco Lopera, Pablo Martínez‐Lage, Ralph N. Martins, Lefkos Middleton, José Luís Molinuevo, Manuel Montero‐Odasso, So Young Moon, Kristal Morales‐Pérez, Ricardo Nitríni, Haakon B. Nygaard, Yoo K. Park, Markku Peltonen, Chengxuan Qiu, Yakeel T. Quiroz, Rema Raman, Naren P. Rao, Vijayalakshmi Ravindranath, Anna Rosenberg, Takashi Sakurai, Rosa María Salinas, Philip Scheltens, Gustavo Sevlever, Hilkka Soininen, Ana Luisa Sosa, Cláudia Kimie Suemoto, Mikel Tainta, Lina Velilla, Yongxiang Wang, Rachel A. Whitmer, Xin Xu, Lisa J. Bain, Alina Solomon, Tiia Ngandu, María C. Carrillo - Alzheimer s & Dementia 2020 cited by 521

  6. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

    Authors: Raymond Scott Turner, Ronald G. Thomas, Suzanne Craft, Christopher H. van Dyck, Jacobo Mintzer, Brigid Reynolds, James B. Brewer, Robert A. Rissman, Rema Raman, Paul Aisen, For the Alzheimer's Disease Cooperative Study, Alzheimer's Disease Cooperative Study, Jacobo Mintzer, Brent A. Reynolds, Jason Karlawish, Douglas Galasko, Judith L. Heidebrink, Neel Aggarwal, Neill R. Graff‐Radford, Mary Sano, Ronald C. Petersen, Katheryn A. Bell, Rachelle S. Doody, Alisha J Smith, Charles Bernick, A. Porteinsson, Pierre N. Tariot, Ruth A. Mulnard, A. Lerner, Luisa‐Sophie Schneider, Jane C. Burns, Murray A. Raskind, Steven H. Ferris, Gregory A. Jicha, M. Quiceno, Thomas O. Obisesan, Paul B. Rosenberg, Daniel Weintraub, Karl Kieburtz, Bruce L. Miller, Richard J. Kryscio, G. Alexopoulis - Neurology 2015 cited by 699

  7. A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

    Authors: Rachelle S. Doody, Rema Raman, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Feng He, Xiaoying Sun, Ronald G. Thomas, Paul Aisen, Eric Siemers, Gopalan Sethuraman, Richard C. Mohs - New England Journal of Medicine 2013 cited by 1,213

  8. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia

    Authors: Suzanne Craft, Rema Raman, Tiffany W. Chow, Michael S. Rafii, Chung‐Kai Sun, Robert A. Rissman, Michael Donohue, James B. Brewer, Cecily Jenkins, Kelly Harless, Devon Gessert, Paul Aisen - JAMA Neurology 2020 cited by 368

  9. Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease

    Authors: Robert A. Rissman, Oliver Langford, Rema Raman, Michael Donohue, Sara Abdel‐Latif, Matthew R. Meyer, Traci L. Wente‐Roth, Kristopher M. Kirmess, Jennifer Ngolab, Charisse N. Winston, Gustavo Jimenez‐Maggiora, Michael S. Rafii, Pallavi Sachdev, Tim West, Kevin E. Yarasheski, Joel B. Braunstein, Michael C. Irizarry, Keith A. Johnson, Paul Aisen, Reisa A. Sperling, for the AHEAD 3‐45 Study team - Alzheimer s & Dementia 2023 cited by 145

  10. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals

    Authors: Reisa A. Sperling, Michael Donohue, Rema Raman, Chung‐Kai Sun, R. Yaari, Karen C. Holdridge, Eric Siemers, Keith A. Johnson, Paul Aisen, for the A4 Study Team - JAMA Neurology 2020 cited by 329

  11. Anatomically interpretable deep learning of brain age captures domain-specific cognitive impairment

    Authors: Chenzhong Yin, Phoebe Imms, Mingxi Cheng, Anar Amgalan, Nahian F. Chowdhury, Roy J Massett, Nikhil N. Chaudhari, Xinghe Chen, Paul M. Thompson, Paul Bogdan, Andrei Irimia, the Alzheimer’s Disease Neuroimaging Initiative, Michael W. Weiner, Paul Aisen, Ronald Petersen, Michael W. Weiner, Paul Aisen, Ronald Petersen, Clifford R. Jack, William Jagust, John Q. Trojanowki, Arthur W. Toga, Laurel Beckett, Robert C. Green, Andrew J. Saykin, John C. Morris, Richard J. Perrin, Leslie M. Shaw, Zaven S. Khachaturian, María C. Carrillo, William Z. Potter, Lisa L. Barnes, Marie Bernard, Héctor Alfredo Baptista González, Carole Ho, John K. Hsiao, Jonathan Jackson, Eliezer Masliah, Donna Masterman, Ozioma C. Okonkwo, Richard J. Perrin, Laurie Ryan, Nina Silverberg, Adam Fleisher, Eli Lilly, Michael W. Weiner, Diana Truran Sacrey, Juliet Fockler, Cat Conti, Dallas P. Veitch, John Neuhaus, Chengshi Jin, Rachel L. Nosheny, Miriam T. Ashford, Derek Flenniken, Adrienne Kormos, Robert C. Green, Tom Montine, Cat Conti, Ronald Petersen, Paul Aisen, Michael S. Rafii, Rema Raman, Gustavo Jiménez, Michael Donohue, Devon Gessert, Jennifer Salazar, Caileigh Zimmerman, Yuliana Cabrera, Sarah Walter, Garrett Miller, Godfrey Coker, Taylor Clanton, Lindsey Hergesheimer, Stephanie Smith, Olusegun Adegoke, Payam Mahboubi, Shelley Moore, Jeremy Pizzola, Elizabeth Shaffer, Brittany Sloan, Laurel Beckett, Danielle Harvey, Michael Donohue, Clifford R. Jack, Arvin Forghanian-Arani, Bret Borowski, Chad Ward, Christopher G. Schwarz, David Jones, Jeff Gunter, Kejal Kantarci, Matthew L. Senjem, Prashanthi Vemuri, Robert I. Reid, Nick C. Fox, Ian B. Malone, Paul M. Thompson, Sophia I. Thomopoulos, Talia M. Nir and 542 more - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 120

  12. Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans

    Authors: Paul Aisen, Ronald C. Petersen, Michael Donohue, Anthony Gamst, Rema Raman, Ronald G. Thomas, Sarah Walter, John Q. Trojanowski, Leslie M. Shaw, Laurel Beckett, Clifford R. Jack, William J. Jagust, Arthur W. Toga, Andrew J. Saykin, John C. Morris, Robert C. Green, Michael W. Weiner, Alzheimer's Disease Neuroimaging Initiative - Alzheimer s & Dementia 2010 cited by 526

  13. Early-stage Alzheimer disease: getting trial-ready

    Authors: Paul Aisen, Gustavo Jimenez‐Maggiora, Michael S. Rafii, Sarah Walter, Rema Raman - Nature Reviews Neurology 2022 cited by 150

  14. Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease

    Authors: Reisa A. Sperling, David Henley, Paul Aisen, Rema Raman, Michael Donohue, Karin Ernström, Michael S. Rafii, Johannes Streffer, Yingqi Shi, Keith Karcher, Nandini Raghavan, Yevgen Tymofyeyev, Jennifer Bogert, H. Robert Brashear, Gerald Novak, John Thipphawong, Ziad S. Saad, Hartmuth C. Kolb, Hany Rofael, Panna Sanga, Gary Romano - JAMA Neurology 2021 cited by 110

  15. Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease

    Authors: Joseph F. Quinn, Rema Raman, Ronald G. Thomas, Karin Yurko‐Mauro, Edward Nelson, Christopher van Dyck, James E. Galvin, Jennifer A. Emond, Clifford R. Jack, Michael W. Weiner, Lynne Shinto, Paul Aisen - JAMA 2010 cited by 753

  16. Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial

    Authors: Rema Raman, Yakeel T. Quiroz, Oliver Langford, Jiyoon Choi, Marina Ritchie, Morgan Baumgartner, Dorene M. Rentz, Neelum T. Aggarwal, Paul Aisen, Reisa A. Sperling, Joshua D. Grill - JAMA Network Open 2021 cited by 163

  17. Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease

    Authors: Gorazd B. Stokin, Concepción Lillo, Tomás L. Falzone, Richard G. Brusch, Edward Rockenstein, Stephanie L. Mount, Rema Raman, Peter Davies, Eliezer Masliah, David S. Williams, Lawrence S.B. Goldstein - Science 2005 cited by 1,236

  18. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease

    Authors: Zahra Shirzadi, Stephanie A. Schultz, Wai‐Ying Wendy Yau, Nelly Joseph‐Mathurin, Colleen Fitzpatrick, Raina Levin, Kejal Kantarci, Gregory M. Preboske, Clifford R. Jack, Martin R. Farlow, Jason Hassenstab, Mathias Jucker, John C. Morris, Chengjie Xiong, Celeste M. Karch, Allan I. Levey, Brian A. Gordon, Peter R. Schofield, Stephen Salloway, Richard J. Perrin, Eric McDade, Johannes Levin, Carlos Cruchaga, Ricardo Allegri, Nick C. Fox, Alison Goate, Gregory S. Day, Robert A. Koeppe, Helena C. Chui, Sarah Berman, Hiroshi Mori, Raquel Sánchez‐Valle, Jae‐Hong Lee, Pedro Rosa‐Neto, Myuri Ruthirakuhan, Che‐Yuan Wu, Walter Swardfager, Tammie L.S. Benzinger, Hamid R. Sohrabi, Ralph N. Martins, Randall J. Bateman, Keith A. Johnson, Reisa A. Sperling, Steven M. Greenberg, Aaron P. Schultz, Jasmeer P. Chhatwal, Dominantly Inherited Alzheimer Network and the Alzheimer’s Disease Neuroimaging Initiative, Michael W. Weiner, Paul Aisen, Ronald Petersen, Clifford R. Jack, William J. Jagust, John Q. Trojanowki, Arthur W. Toga, Laurel Beckett, Robert C. Green, Andrew J. Saykin, John C. Morris, Richard J. Perrin, Leslie M. Shaw, Zaven S. Khachaturian, Maria Carrillo, William Z. Potter, Lisa L. Barnes, Marie Bernard, Héctor Alfredo Baptista González, Carole Ho, John Hsiao, Jonathan Jackson, Eliezer Masliah, Donna Masterman, Ozioma C. Okonkwo, Laurie Ryan, Nina Silverberg, Adam Fleisher, Diana Truran Sacrey, Juliet Fockler, Cat Conti, Dallas P. Veitch, John Neuhaus, Chengshi Jin, Rachel L. Nosheny, Miriam T. Ashford, Derek Flenniken, Adrienne Kormos, Tom Montine, Michael S. Rafii, Rema Raman, Gustavo Jiménez, Michael Donohue, Devon Gessert, Jennifer Salazar, Caileigh Zimmerman, Yuliana Cabrera, Sarah Walter, Garrett Miller, Godfrey Coker, Taylor Clanton, Lindsey Hergesheimer, Stephanie Smith and 434 more - JAMA Neurology 2023 cited by 87

  19. Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer’s disease: a randomized trial

    Authors: Derek Kellar, Thomas C. Register, Samuel N. Lockhart, Paul Aisen, Rema Raman, Robert A. Rissman, James B. Brewer, Suzanne Craft - Scientific Reports 2022 cited by 64

  20. Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity

    Authors: Alejandro Costoya‐Sánchez, Alexis Moscoso, Jesús Silva‐Rodríguez, Michael J. Pontecorvo, Michael D. Devous, Pablo Aguiar, Michael Schöll, Michel J. Grothe, Alzheimer’s Disease Neuroimaging Initiative and the Harvard Aging Brain Study, Michael W. Weiner, Paul Aisen, Ronald Petersen, Clifford R. Jack, William J. Jagust, John Q. Trojanowki, Arthur W Toga, Laurel Beckett, Robert C Green, Andrew J. Saykin, John C. Morris, Richard J. Perrin, Leslie M. Shaw, Zaven S. Khachaturian, María C. Carrillo, William Z. Potter, Lisa L. Barnes, Marie Bernard, Héctor Alfredo Baptista González, Carole Ho, John Hsiao, Jonathan Jackson, Eliezer Masliah, Donna Masterman, Ozioma C. Okonkwo, Laurie Ryan, Nina Silverberg, Adam Fleisher, Diana Truran Sacrey, Juliet Fockler, Cat Conti, Dallas P. Veitch, John Neuhaus, Chengshi Jin, Rachel L. Nosheny, Mariam Ashford, Derek Flenniken, Adrienne Kormos, Tom Montine, Michael S. Rafii, Rema Raman, Gustavo Jiménez, Michael Donohue, Devon Gessert, Jennifer Salazar, Caileigh Zimmerman, Yuliana Cabrera, Sarah Walter, Garrett Miller, Godfrey Coker, Taylor Clanton, Lindsey Hergesheimer, Stephanie Smith, Olusegun Adegoke, Payam Mahboubi, Shelley Moore, Jeremy Pizzola, Elizabeth Shaffer, Danielle Harvey, Arvin Forghanian-Arani, Bret Borowski, Chad Ward, Christopher G. Schwarz, David T. Jones, Jeff Gunter, Kejal Kantarci, Matthew L. Senjem, Prashanthi Vemuri, Robert C. Reid, Nick C. Fox, Ian B. Malone, Paul M. Thompson, Sophia I. Thomopoulos, Talia M. Nir, Neda Jahanshad, Charles DeCarli, Alexander Knaack, Evan Fletcher, Duygu Tosun, Stephanie R Chen, Mark Choe, Karen Crawford, Paul A Yuschkevich, Sandhitsu R. Das, Robert A. Koeppe, Eric M. Reiman, Kewei Chen, Chet Mathis, Susan Landau, Nigel J. Cairns, Erin Householder and 45 more - JAMA Neurology 2023 cited by 46

  21. Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies

    Authors: Reisa A. Sperling, Michael Donohue, Robert A. Rissman, Keith A. Johnson, Dorene M. Rentz, Joshua D. Grill, Judith L. Heidebrink, Cathy A. Jenkins, Gustavo Jimenez‐Maggiora, Oliver Langford, Aiyi Liu, Rema Raman, R. Yaari, Karen C. Holdridge, J R Sims, Paul Aisen - The Journal of Prevention of Alzheimer s Disease 2024 cited by 87

  22. Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer's Disease

    Authors: Derek Kellar, Samuel N. Lockhart, Paul Aisen, Rema Raman, Robert A. Rissman, James B. Brewer, Suzanne Craft - The Journal of Prevention of Alzheimer s Disease 2021 cited by 82

  23. Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease

    Authors: Christina B. Young, Joseph R. Winer, Kyan Younes, Karly Alex Cody, Tobey J. Betthauser, Sterling C. Johnson, Aaron P. Schultz, Reisa A. Sperling, Michael D. Greicius, Inma Cobos, Kathleen L. Poston, Elizabeth C. Mormino, Alzheimer’s Disease Neuroimaging Initiative and the Harvard Aging Brain Study, Michael W. Weiner, Paul Aisen, Ronald C. Petersen, Clifford R. Jack, William J. Jagust, John Q. Trojanowki, Arthur W. Toga, Laurel Beckett, Robert C. Green, Andrew J. Saykin, John C. Morris, Richard J. Perrin, Leslie M. Shaw, Zaven S. Khachaturian, María C. Carrillo, William Z. Potter, Lisa L. Barnes, Marie Bernard, Héctor Alfredo Baptista González, Carole Ho, John Hsiao, Jonathan Jackson, Eliezer Masliah, Donna Masterman, Ozioma C. Okonkwo, Laurie Ryan, Nina Silverberg, Adam Fleisher, Diana Truran Sacrey, Juliet Fockler, Cat Conti, Dallas P. Veitch, John Neuhaus, Chengshi Jin, Rachel L. Nosheny, Mariam Ashford, Derek Flenniken, Adrienne Kormos, Tom Montine, Michael S. Rafii, Rema Raman, Gustavo Jiménez, Michael Donohue, Devon Gessert, Jennifer Salazar, Caileigh Zimmerman, Yuliana Cabrera, Sarah Walter, Garrett Miller, Godfrey Coker, Taylor Clanton, Lindsey Hergesheimer, Stephanie Smith, Olusegun Adegoke, Payam Mahboubi, Shelley Moore, Jeremy Pizzola, Elizabeth Shaffer, Danielle Harvey, Arvin Forghanian-Arani, Bret Borowski, Chad Ward, Christopher G. Schwarz, David T. Jones, Jeff Gunter, Kejal Kantarci, Matthew L. Senjem, Prashanthi Vemuri, Robert I. Reid, Nick C. Fox, Ian B. Malone, Paul M. Thompson, Sophia I. Thomopoulos, Talia M. Nir, Neda Jahanshad, Charles DeCarli, Alexander Knaack, Evan Fletcher, Duygu Tosun, Stephanie R Chen, Mark Choe, Karen Crawford, Paul A Yuschkevich, Sandhitsu R. Das, Robert A. Koeppe, Eric M. Reiman, Kewei Chen and 21 more - JAMA Neurology 2022 cited by 78

  24. Clinical criteria for limbic‐predominant age‐related TDP‐43 encephalopathy

    Authors: David A. Wolk, Peter T. Nelson, Liana G. Apostolova, Konstantinos Arfanakis, Patricia A. Boyle, Cynthia M. Carlsson, Nick Corriveau‐Lecavalier, Penny A. Dacks, Bradford C. Dickerson, Kimiko Domoto‐Reilly, Brittany N. Dugger, Rebecca M. Edelmayer, David W. Fardo, Michel J. Grothe, Timothy J. Hohman, David J. Irwin, Gregory A. Jicha, David T. Jones, Claudia H. Kawas, Edward B. Lee, Karen D. Lincoln, Gladys E. Maestre, Elizabeth C. Mormino, Chiadi U. Onyike, Ronald C. Petersen, Gil D. Rabinovici, Rosa Rademakers, Rema Raman, Katya Rascovsky, Robert A. Rissman, Emily Rogalskı, Philip Scheltens, Reisa A. Sperling, Hyun‐Sik Yang, Lei Yu, Henrik Zetterberg, Julie A. Schneider - Alzheimer s & Dementia 2025 cited by 70